<?xml version="1.0" encoding="ASCII"?>
<biogps><data><item key="owner">ArrayExpress Uploader</item><item key="pop_total">0</item><item key="species">human</item><item key="factors"><item><item key="GSM686287"><item key="T STAGE">1a</item><item key="GENDER">female</item><item key="PATHOLOGICAL TYPE">BronchioloAlveolar Carcinoma</item><item key="N STAGE">0</item><item key="AGE AT DX">68</item><item key="STAGE GROUPING">Ia</item></item></item><item><item key="GSM686288"><item key="T STAGE">2a</item><item key="GENDER">male</item><item key="PATHOLOGICAL TYPE">AdenoCarcinoma-mixed invasive</item><item key="N STAGE">0</item><item key="AGE AT DX">71</item><item key="STAGE GROUPING">Ib</item></item></item><item><item key="GSM686289"><item key="T STAGE">1a</item><item key="GENDER">female</item><item key="PATHOLOGICAL TYPE">BronchioloAlveolar Carcinoma</item><item key="N STAGE">0</item><item key="AGE AT DX">71</item><item key="STAGE GROUPING">Ia</item></item></item><item><item key="GSM686290"><item key="T STAGE">1a</item><item key="GENDER">male</item><item key="PATHOLOGICAL TYPE">BronchioloAlveolar Carcinoma</item><item key="N STAGE">0</item><item key="AGE AT DX">74</item><item key="STAGE GROUPING">Ia</item></item></item><item><item key="GSM68629"><item key="T STAGE">2a</item><item key="GENDER">female</item><item key="PATHOLOGICAL TYPE">AdenoCarcinoma-mixed invasive</item><item key="N STAGE">0</item><item key="AGE AT DX">80</item><item key="STAGE GROUPING">Ib</item></item></item><item><item key="GSM686292"><item key="T STAGE">1b</item><item key="GENDER">female</item><item key="PATHOLOGICAL TYPE">BronchioloAlveolar Carcinoma</item><item key="N STAGE">0</item><item key="AGE AT DX">86</item><item key="STAGE GROUPING">Ia</item></item></item><item><item key="GSM686293"><item key="T STAGE">1a</item><item key="GENDER">female</item><item key="PATHOLOGICAL TYPE">AdenoCarcinoma-mixed invasive</item><item key="N STAGE">0</item><item key="AGE AT DX">65</item><item key="STAGE GROUPING">Ia</item></item></item><item><item key="GSM686294"><item key="T STAGE">1a</item><item key="GENDER">female</item><item key="PATHOLOGICAL TYPE">BronchioloAlveolar Carcinoma</item><item key="N STAGE">0</item><item key="AGE AT DX">70</item><item key="STAGE GROUPING">Ia</item></item></item><item><item key="GSM686295"><item key="T STAGE">1b</item><item key="GENDER">male</item><item key="PATHOLOGICAL TYPE">AdenoCarcinoma-mixed invasive</item><item key="N STAGE">2</item><item key="AGE AT DX">78</item><item key="STAGE GROUPING">IIIa</item></item></item><item><item key="GSM686296"><item key="T STAGE">2a</item><item key="GENDER">male</item><item key="PATHOLOGICAL TYPE">AdenoCarcinoma-mixed invasive</item><item key="N STAGE">0</item><item key="AGE AT DX">63</item><item key="STAGE GROUPING">Ib</item></item></item><item><item key="GSM686297"><item key="T STAGE">1a</item><item key="GENDER">female</item><item key="PATHOLOGICAL TYPE">AdenoCarcinoma-mixed invasive</item><item key="N STAGE">0</item><item key="AGE AT DX">74</item><item key="STAGE GROUPING">Ia</item></item></item><item><item key="GSM686298"><item key="T STAGE">1a</item><item key="GENDER">male</item><item key="PATHOLOGICAL TYPE">AdenoCarcinoma-mixed invasive</item><item key="N STAGE">0</item><item key="AGE AT DX">73</item><item key="STAGE GROUPING">Ia</item></item></item><item><item key="GSM686299"><item key="T STAGE">2a</item><item key="GENDER">male</item><item key="PATHOLOGICAL TYPE">AdenoCarcinoma-mixed invasive</item><item key="N STAGE">1</item><item key="AGE AT DX">61</item><item key="STAGE GROUPING">IIa</item></item></item><item><item key="GSM686300"><item key="T STAGE">3</item><item key="GENDER">female</item><item key="PATHOLOGICAL TYPE">BronchioloAlveolar Carcinoma</item><item key="N STAGE">0</item><item key="AGE AT DX">75</item><item key="STAGE GROUPING">IIb</item></item></item><item><item key="GSM68630"><item key="T STAGE">1a</item><item key="GENDER">female</item><item key="PATHOLOGICAL TYPE">AdenoCarcinoma-mixed invasive</item><item key="N STAGE">0</item><item key="AGE AT DX">67</item><item key="STAGE GROUPING">Ia</item></item></item><item><item key="GSM686302"><item key="T STAGE">1a</item><item key="GENDER">female</item><item key="PATHOLOGICAL TYPE">BronchioloAlveolar Carcinoma</item><item key="N STAGE">0</item><item key="AGE AT DX">67</item><item key="STAGE GROUPING">Ia</item></item></item><item><item key="GSM686303"><item key="T STAGE">1a</item><item key="GENDER">male</item><item key="PATHOLOGICAL TYPE">AdenoCarcinoma-mixed invasive</item><item key="N STAGE">0</item><item key="AGE AT DX">70</item><item key="STAGE GROUPING">Ia</item></item></item><item><item key="GSM686304"><item key="T STAGE">1a</item><item key="GENDER">male</item><item key="PATHOLOGICAL TYPE">AdenoCarcinoma-mixed invasive</item><item key="N STAGE">0</item><item key="AGE AT DX">66</item><item key="STAGE GROUPING">Ia</item></item></item><item><item key="GSM686305"><item key="T STAGE">1b</item><item key="GENDER">female</item><item key="PATHOLOGICAL TYPE">AdenoCarcinoma-mixed invasive</item><item key="N STAGE">0</item><item key="AGE AT DX">70</item><item key="STAGE GROUPING">Ia</item></item></item><item><item key="GSM686306"><item key="T STAGE">1a</item><item key="GENDER">female</item><item key="PATHOLOGICAL TYPE">BronchioloAlveolar Carcinoma</item><item key="N STAGE">0</item><item key="AGE AT DX">53</item><item key="STAGE GROUPING">Ia</item></item></item><item><item key="GSM686307"><item key="T STAGE">1a</item><item key="GENDER">female</item><item key="PATHOLOGICAL TYPE">BronchioloAlveolar Carcinoma</item><item key="N STAGE">0</item><item key="AGE AT DX">72</item><item key="STAGE GROUPING">Ia</item></item></item><item><item key="GSM686308"><item key="T STAGE">2a</item><item key="GENDER">female</item><item key="PATHOLOGICAL TYPE">AdenoCarcinoma-mixed invasive</item><item key="N STAGE">0</item><item key="AGE AT DX">57</item><item key="STAGE GROUPING">Ib</item></item></item><item><item key="GSM686302"><item key="T STAGE">1a</item><item key="GENDER">female</item><item key="PATHOLOGICAL TYPE">BronchioloAlveolar Carcinoma</item><item key="N STAGE">0</item><item key="AGE AT DX">67</item><item key="STAGE GROUPING">Ia</item></item></item><item><item key="GSM686310"><item key="T STAGE">1b</item><item key="GENDER">female</item><item key="PATHOLOGICAL TYPE">AdenoCarcinoma-mixed invasive</item><item key="N STAGE">0</item><item key="AGE AT DX">79</item><item key="STAGE GROUPING">Ia</item></item></item><item><item key="GSM6863"><item key="T STAGE">3</item><item key="GENDER">female</item><item key="PATHOLOGICAL TYPE">BronchioloAlveolar Carcinoma</item><item key="N STAGE">0</item><item key="AGE AT DX">73</item><item key="STAGE GROUPING">IIb</item></item></item><item><item key="GSM686312"><item key="T STAGE">1a</item><item key="GENDER">female</item><item key="PATHOLOGICAL TYPE">AdenoCarcinoma-mixed invasive</item><item key="N STAGE">0</item><item key="AGE AT DX">61</item><item key="STAGE GROUPING">Ia</item></item></item><item><item key="GSM686313"><item key="T STAGE">2a</item><item key="GENDER">female</item><item key="PATHOLOGICAL TYPE">AdenoCarcinoma-mixed invasive</item><item key="N STAGE">0</item><item key="AGE AT DX">65</item><item key="STAGE GROUPING">Ib</item></item></item><item><item key="GSM686314"><item key="T STAGE">1a</item><item key="GENDER">female</item><item key="PATHOLOGICAL TYPE">AdenoCarcinoma-mixed invasive</item><item key="N STAGE">2</item><item key="AGE AT DX">61</item><item key="STAGE GROUPING">IIIa</item></item></item><item><item key="GSM686315"><item key="T STAGE">2a</item><item key="GENDER">male</item><item key="PATHOLOGICAL TYPE">AdenoCarcinoma-mixed invasive</item><item key="N STAGE">0</item><item key="AGE AT DX">59</item><item key="STAGE GROUPING">Ib</item></item></item><item><item key="GSM686316"><item key="T STAGE">1a</item><item key="GENDER">female</item><item key="PATHOLOGICAL TYPE">BronchioloAlveolar Carcinoma</item><item key="N STAGE">0</item><item key="AGE AT DX">82</item><item key="STAGE GROUPING">Ia</item></item></item><item><item key="GSM686317"><item key="T STAGE">1a</item><item key="GENDER">male</item><item key="PATHOLOGICAL TYPE">BronchioloAlveolar Carcinoma</item><item key="N STAGE">0</item><item key="AGE AT DX">90</item><item key="STAGE GROUPING">Ia</item></item></item><item><item key="GSM686318"><item key="T STAGE">2a</item><item key="GENDER">female</item><item key="PATHOLOGICAL TYPE">AdenoCarcinoma-mixed invasive</item><item key="N STAGE">0</item><item key="AGE AT DX">88</item><item key="STAGE GROUPING">Ib</item></item></item><item><item key="GSM686319"><item key="T STAGE">2a</item><item key="GENDER">female</item><item key="PATHOLOGICAL TYPE">AdenoCarcinoma-mixed invasive</item><item key="N STAGE">2</item><item key="AGE AT DX">62</item><item key="STAGE GROUPING">IIIa</item></item></item><item><item key="GSM686320"><item key="T STAGE">2a</item><item key="GENDER">female</item><item key="PATHOLOGICAL TYPE">AdenoCarcinoma-mixed invasive</item><item key="N STAGE">2</item><item key="AGE AT DX">59</item><item key="STAGE GROUPING">IIIa</item></item></item><item><item key="GSM68632"><item key="T STAGE">2a</item><item key="GENDER">female</item><item key="PATHOLOGICAL TYPE">BronchioloAlveolar Carcinoma</item><item key="N STAGE">0</item><item key="AGE AT DX">59</item><item key="STAGE GROUPING">Ib</item></item></item><item><item key="GSM686322"><item key="T STAGE">1a</item><item key="GENDER">female</item><item key="PATHOLOGICAL TYPE">BronchioloAlveolar Carcinoma</item><item key="N STAGE">0</item><item key="AGE AT DX">64</item><item key="STAGE GROUPING">Ia</item></item></item><item><item key="GSM686323"><item key="T STAGE">1b</item><item key="GENDER">female</item><item key="PATHOLOGICAL TYPE">BronchioloAlveolar Carcinoma</item><item key="N STAGE">0</item><item key="AGE AT DX">73</item><item key="STAGE GROUPING">Ia</item></item></item><item><item key="GSM686324"><item key="T STAGE">4</item><item key="GENDER">female</item><item key="PATHOLOGICAL TYPE">AdenoCarcinoma-mixed invasive</item><item key="N STAGE">0</item><item key="AGE AT DX">63</item><item key="STAGE GROUPING">IIIa</item></item></item><item><item key="GSM686308"><item key="T STAGE">2a</item><item key="GENDER">female</item><item key="PATHOLOGICAL TYPE">AdenoCarcinoma-mixed invasive</item><item key="N STAGE">0</item><item key="AGE AT DX">57</item><item key="STAGE GROUPING">Ib</item></item></item><item><item key="GSM686326"><item key="T STAGE">1a</item><item key="GENDER">female</item><item key="PATHOLOGICAL TYPE">BronchioloAlveolar Carcinoma</item><item key="N STAGE">0</item><item key="AGE AT DX">55</item><item key="STAGE GROUPING">Ia</item></item></item></item><item key="id">3987</item><item key="ownerprofile_id">arrayexpress_sid</item><item key="platform">4</item><item key="summary_wrapped">The World Health Organization has subclassified adenocarcinoma based upon predominant cell morphology and growth pattern such as...</item><item key="geo_gse_id">E-GEOD-27716</item><item key="owner_profile">/profile/8773/arrayexpressuploader</item><item key="factor_count">6</item><item key="sample_count">40</item><item key="tags"><item>adenocarcinoma</item><item>carcinoma</item><item>cell</item><item>cell morphology</item><item>lung</item><item>lung adenocarcinoma</item></item><item key="lastmodified">Dec.12, 2014</item><item key="is_default">False</item><item key="geo_gds_id"/><item key="slug">expression-data-from-columbia-lung-adenocarcinoma</item><item key="geo_id_plat">E-GEOD-27716_A-AFFY-44</item><item key="name">Expression data from Columbia Lung Adenocarcinoma Human Tumor Cells</item><item key="created">Sep.15, 2014</item><item key="summary">The World Health Organization has subclassified adenocarcinoma based upon predominant cell morphology and growth pattern such as bronchioloalveolar carcinoma (BAC), adenocarcinoma with mixed subtypes (AC-mixed), and homogenously invasive tumors with a variety of histological patterns Pure invasive adenocarcinomas are often devoid of bronchioloalveolar morphology. The clinical importance of lung adenocarcinoma invasion is supported by several recent studies  indicating that the risk of death in non-mucinous BAC  is significantly lower than that of pure invasive tumors and in tumors with greater than 0.6 cm of fibrosis or linear invasion (J Thorac Oncol 6:244-285) To identify human tumor cell signatures associated with lung adenocarcinoma subtype and invasion, we performed microarray gene expression profiling of microdissected tumor cells noninvasive AC  and AC-Mixed invasive tumors. 17 cases of noninvasive AC tumors and 23 cases of AC-mixed subtype invasive lung adenocarcinomas resected from 2002 to 2006 were examined (Columbia Lung Adenocarcinoma dataset)</item><item key="source">http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-27716</item><item key="sample_source">http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-27716/samples/</item></data></biogps>
